Guardant Health
GH
#1154
Rank
โ‚น1.832 T
Marketcap
โ‚น13,543
Share price
1.30%
Change (1 day)
60.02%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of June 2026 : -โ‚น20.8 Billion

According to Guardant Health 's latest financial reports the company has -โ‚น20.8 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-โ‚น8.92 Billion-25.59%
2024-12-31$-โ‚น11.98 Billion-190.69%
2023-12-31$โ‚น13.21 B165.27%
2022-12-31$โ‚น4.97 B-89.63%
2021-12-31$โ‚น48.00 B-51.58%
2020-12-31$โ‚น99.14 B63.95%
2019-12-31$โ‚น60.47 B64.74%
2018-12-31$โ‚น36.70 B86.28%
2017-12-31$โ‚น19.70 B263.84%
2016-12-31$โ‚น5.41 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Neogen
NEOG
โ‚น194.68 B-1,036.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚น169.96 B-917.30%๐Ÿ‡บ๐Ÿ‡ธ USA